Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FB101 Intervention in Asymptomatic Healthy Volunteers Who Have Undergone Vaginal Microbiome Screening - a Randomised, Double-blind, Placebo-controlled Study

NCT05114031 is registered in ClinicalTrials.gov with Freya Biosciences ApS as lead sponsor.

NCT NCT05114031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05114031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FB101 Intervention in Asymptomatic Healthy Volunteers Who Have Undergone Vaginal Microbiome Screening - a Randomised, Double-blind, Placebo-controlled Study
Lead sponsor
Freya Biosciences ApS
Phase
Not applicable
Overall status
Completed
Start date
October 20, 2021
Completion date
February 1, 2023
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vaginal flora imbalance